Published in Am J Hum Genet on March 01, 1992
Medulloblastomics: the end of the beginning. Nat Rev Cancer (2012) 3.01
Molecular genetics of neurofibromatosis type 1 (NF1). J Med Genet (1996) 1.83
Losses of chromosomes 1p and 3q are early genetic events in the development of sporadic pheochromocytomas. Am J Pathol (2000) 1.04
Physical deletion of the p53 gene in bladder cancer. Detection by fluorescence in situ hybridization. Am J Pathol (1994) 1.00
The role of the membrane cytoskeleton cross-linker ezrin in medulloblastoma cells. Neuro Oncol (2008) 0.94
Deletion mapping on chromosome 17p in medulloblastoma. Br J Cancer (1997) 0.89
Just say no to ATOH: how HIC1 methylation might predispose medulloblastoma to lineage addiction. Cancer Res (2008) 0.86
Deciphering HIC1 control pathways to reveal new avenues in cancer therapeutics. Expert Opin Ther Targets (2013) 0.84
Identification of an unbalanced cryptic translocation t(9;17)(q34.3;p13.3) in a child with dysmorphic features. J Med Genet (1995) 0.84
Comparative genomic hybridization detects many recurrent imbalances in central nervous system primitive neuroectodermal tumours in children. Br J Cancer (1999) 0.83
MicroRNA 22 regulates cell cycle length in cerebellar granular neuron precursors. Mol Cell Biol (2013) 0.81
Effects of basic fibroblast growth factor on the differentiation, growth, and viability of a new human medulloblastoma cell line (UM-MB1). Am J Pathol (1997) 0.76
Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science (1990) 16.68
The p53 tumour suppressor gene. Nature (1991) 14.49
Attachment of a 40-base-pair G + C-rich sequence (GC-clamp) to genomic DNA fragments by the polymerase chain reaction results in improved detection of single-base changes. Proc Natl Acad Sci U S A (1989) 13.66
Mutations in the p53 gene occur in diverse human tumour types. Nature (1989) 13.62
Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science (1989) 11.53
Detection and localization of single base changes by denaturing gradient gel electrophoresis. Methods Enzymol (1987) 10.90
Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med (1985) 7.79
Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature (1991) 7.49
Characterization of the human p53 gene. Mol Cell Biol (1986) 4.33
A novel strategy for constructing clustered point mutations. Nucleic Acids Res (1985) 3.39
Loss of heterozygosity on chromosomes 3, 13, and 17 in small-cell carcinoma and on chromosome 3 in adenocarcinoma of the lung. Proc Natl Acad Sci U S A (1987) 2.50
Clonal genomic alterations in glioma malignancy stages. Cancer Res (1988) 2.39
Loss of heterozygosity for the short arm of chromosome 1 in human neuroblastomas: correlation with N-myc amplification. Proc Natl Acad Sci U S A (1989) 2.25
The cerebellar medulloblastoma and its relationship to primitive neuroectodermal tumors. J Neuropathol Exp Neurol (1983) 2.22
A systematic approach for detecting high-frequency restriction fragment length polymorphisms using large genomic probes. Am J Hum Genet (1985) 2.12
Evidence implicating at least two genes on chromosome 17p in breast carcinogenesis. Lancet (1990) 1.64
Infrequent p53 gene mutations in medulloblastomas. Cancer Res (1991) 1.62
A genetic map of human chromosome 17p. Genomics (1990) 1.33
Identification of a germ-line mutation in the p53 gene in a patient with an intracranial ependymoma. Proc Natl Acad Sci U S A (1991) 1.23
Second international workshop on human chromosome 17. Cytogenet Cell Genet (1991) 1.16
Deletion mapping of the medulloblastoma locus on chromosome 17p. Genomics (1990) 0.97
Medulloblastoma. The identification of prognostic subgroups and implications for multimodality management. Cancer (1983) 0.96
Medulloblastoma: presentation, diagnosis and management. Oncology (Williston Park) (1988) 0.84
Comprehensive human genetic maps: individual and sex-specific variation in recombination. Am J Hum Genet (1998) 19.35
Identification of a gene that causes primary open angle glaucoma. Science (1997) 8.14
Influence of socioeconomic and cultural factors on racial differences in late-stage presentation of breast cancer. JAMA (1998) 4.94
Mutation of a nuclear receptor gene, NR2E3, causes enhanced S cone syndrome, a disorder of retinal cell fate. Nat Genet (2000) 4.81
Pendred syndrome is caused by mutations in a putative sulphate transporter gene (PDS). Nat Genet (1997) 4.43
A comprehensive human linkage map with centimorgan density. Cooperative Human Linkage Center (CHLC). Science (1994) 4.02
The role of specific antibody in alternative complement pathway-mediated opsonophagocytosis of type III, group B Streptococcus. J Exp Med (1980) 3.48
Drosophila p53 is a structural and functional homolog of the tumor suppressor p53. Cell (2000) 3.41
A single EFEMP1 mutation associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophy. Nat Genet (1999) 3.32
Continuous and discontinuous protein antigenic determinants. Nature (1986) 3.26
The forkhead transcription factor gene FKHL7 is responsible for glaucoma phenotypes which map to 6p25. Nat Genet (1998) 3.24
Analysis of myocilin mutations in 1703 glaucoma patients from five different populations. Hum Mol Genet (1999) 3.24
Capsular sialic acid prevents activation of the alternative complement pathway by type III, group B streptococci. J Immunol (1982) 3.23
Clinical features associated with mutations in the chromosome 1 open-angle glaucoma gene (GLC1A) N Engl J Med (1998) 3.18
Immunization of pregnant women with a polysaccharide vaccine of group B streptococcus. N Engl J Med (1988) 3.14
Integrated human genome-wide maps constructed using the CEPH reference panel. Nat Genet (1994) 3.06
Missense mutations in COL8A2, the gene encoding the alpha2 chain of type VIII collagen, cause two forms of corneal endothelial dystrophy. Hum Mol Genet (2001) 3.06
Nonsyndromic autosomal recessive deafness is linked to the DFNB1 locus in a large inbred Bedouin family from Israel. Am J Hum Genet (1995) 3.02
Identification of the gene that, when mutated, causes the human obesity syndrome BBS4. Nat Genet (2001) 2.77
Drosophila immune deficiency (IMD) is a death domain protein that activates antibacterial defense and can promote apoptosis. Dev Cell (2001) 2.68
Positional cloning of a novel gene on chromosome 16q causing Bardet-Biedl syndrome (BBS2). Hum Mol Genet (2001) 2.56
Carrier rates in the midwestern United States for GJB2 mutations causing inherited deafness. JAMA (1999) 2.56
De novo mutations in the CRX homeobox gene associated with Leber congenital amaurosis. Nat Genet (1998) 2.53
Use of a DNA pooling strategy to identify a human obesity syndrome locus on chromosome 15. Hum Mol Genet (1995) 2.50
Mapping of a gene for type 2 diabetes associated with an insulin secretion defect by a genome scan in Finnish families. Nat Genet (1996) 2.48
Mutations in MKKS cause Bardet-Biedl syndrome. Nat Genet (2000) 2.45
Complement factor H gene mutation associated with autosomal recessive atypical hemolytic uremic syndrome. Am J Hum Genet (1999) 2.42
Selective cleavage in the avian retroviral long terminal repeat sequence by the endonuclease associated with the alpha beta form of avian reverse transcriptase. Proc Natl Acad Sci U S A (1983) 2.40
Mutations in the CRB1 gene cause Leber congenital amaurosis. Arch Ophthalmol (2001) 2.38
The Pendred syndrome gene encodes a chloride-iodide transport protein. Nat Genet (1999) 2.32
Butterfly-shaped pigment dystrophy of the fovea caused by a point mutation in codon 167 of the RDS gene. Nat Genet (1993) 2.24
Location of 'continuous' antigenic determinants in the protruding regions of proteins. EMBO J (1986) 2.22
Pitfalls in homozygosity mapping. Am J Hum Genet (2000) 2.12
Phenotypic variation including retinitis pigmentosa, pattern dystrophy, and fundus flavimaculatus in a single family with a deletion of codon 153 or 154 of the peripherin/RDS gene. Arch Ophthalmol (1993) 2.05
Linkage of Bardet-Biedl syndrome to chromosome 16q and evidence for non-allelic genetic heterogeneity. Nat Genet (1993) 2.05
Clinical features of a Stargardt-like dominant progressive macular dystrophy with genetic linkage to chromosome 6q. Arch Ophthalmol (1994) 2.05
Improved set of short-tandem-repeat polymorphisms for screening the human genome. Am J Hum Genet (1997) 2.03
Characterization of FadR, a global transcriptional regulator of fatty acid metabolism in Escherichia coli. Interaction with the fadB promoter is prevented by long chain fatty acyl coenzyme A. J Biol Chem (1992) 1.99
Sets of short tandem repeat polymorphisms for efficient linkage screening of the human genome. Hum Mol Genet (1995) 1.99
Immunogenicity of polysaccharides from type III, group B Streptococcus. J Clin Invest (1978) 1.95
An analysis of allelic variation in the ABCA4 gene. Invest Ophthalmol Vis Sci (2001) 1.90
Mutation analysis of 3 genes in patients with Leber congenital amaurosis. Arch Ophthalmol (2000) 1.89
Allelic variation in the VMD2 gene in best disease and age-related macular degeneration. Invest Ophthalmol Vis Sci (2000) 1.84
Surgical treatment of syringomyelia. Favorable results with syringoperitoneal shunting. J Neurosurg (1984) 1.84
Role of antibody to native type III polysaccharide of group B Streptococcus in infant infection. Pediatrics (1981) 1.83
Skull base and calvarial deformities: association with intracranial changes in craniofacial syndromes. AJNR Am J Neuroradiol (1996) 1.81
Allelic variation in ABCR associated with Stargardt disease but not age-related macular degeneration. Nat Genet (1998) 1.80
Examination of AVPR1a as an autism susceptibility gene. Mol Psychiatry (2004) 1.80
Genetic linkage of vitelliform macular degeneration (Best's disease) to chromosome 11q13. Nat Genet (1992) 1.77
Recurrent meningitis and Mondini dysplasia. Arch Otolaryngol Head Neck Surg (1990) 1.77
Pendred syndrome, DFNB4, and PDS/SLC26A4 identification of eight novel mutations and possible genotype-phenotype correlations. Hum Mutat (2001) 1.77
Construction of small-insert genomic DNA libraries highly enriched for microsatellite repeat sequences. Proc Natl Acad Sci U S A (1992) 1.75
Cloning, sequencing, and expression of the fadD gene of Escherichia coli encoding acyl coenzyme A synthetase. J Biol Chem (1992) 1.75
Revised classification of posterior fossa cysts and cystlike malformations based on the results of multiplanar MR imaging. AJR Am J Roentgenol (1989) 1.74
Linkage analysis of autosomal dominant atrioventricular canal defects: exclusion of chromosome 21. Hum Genet (1994) 1.72
Opsonic specificity of human antibody to the type III polysaccharide of group B Streptococcus. J Infect Dis (1979) 1.71
Mechanism of action of the endonuclease associated with the alpha beta and beta beta forms of avian RNA tumor virus reverse transcriptase. J Virol (1983) 1.70
Localization of the Usher syndrome type ID gene (Ush1D) to chromosome 10. Hum Mol Genet (1996) 1.69
Variation of codons 1961 and 2177 of the Stargardt disease gene is not associated with age-related macular degeneration. Arch Ophthalmol (2001) 1.68
Treatment options and prognosis for multicentric juvenile pilocytic astrocytoma. J Neurosurg (1994) 1.68
Non-secretion of mutant proteins of the glaucoma gene myocilin in cultured trabecular meshwork cells and in aqueous humor. Hum Mol Genet (2001) 1.67
Iron deficiency and glycosylated haemoglobin A. Lancet (1980) 1.62
Interventional neuroradiological management of vein of Galen malformations in the neonate. Neurosurgery (1990) 1.62
Rapid diagnosis of type III group B streptococcal meningitis by latex particle agglutination. J Pediatr (1979) 1.61
Catechol-O-methyl transferase Val158Met gene polymorphism in schizophrenia: working memory, frontal lobe MRI morphology and frontal cerebral blood flow. Mol Psychiatry (2005) 1.61
Opsonophagocytic killing antibody to Pseudomonas aeruginosa mucoid exopolysaccharide in older noncolonized patients with cystic fibrosis. N Engl J Med (1987) 1.59
Difficulties in diagnosis of carcinoma of the breast in patients less than fifty years of age. Surg Gynecol Obstet (1993) 1.57
Molecular genetics of age-related macular degeneration. Hum Mol Genet (2001) 1.55
Autosomal dominant Charcot-Marie-Tooth axonal neuropathy mapped on chromosome 7p (CMT2D). Hum Mol Genet (1996) 1.54
Multicenter trial of sentinel node biopsy for breast cancer using both technetium sulfur colloid and isosulfan blue dye. Ann Surg (2001) 1.53
Progression of multiple cryptic vascular malformations associated with anomalous venous drainage. Case report. J Neurosurg (1994) 1.50
A spectrum of FOXC1 mutations suggests gene dosage as a mechanism for developmental defects of the anterior chamber of the eye. Am J Hum Genet (2001) 1.50
Homozygosity and linkage-disequilibrium mapping of the syndrome of congenital hypoparathyroidism, growth and mental retardation, and dysmorphism to a 1-cM interval on chromosome 1q42-43. Am J Hum Genet (1998) 1.50
Night blindness in Sorsby's fundus dystrophy reversed by vitamin A. Nat Genet (1995) 1.50
Long-term sequelae of group B streptococcal meningitis in infants. J Pediatr (1985) 1.49
Linkage of posterior polymorphous corneal dystrophy to 20q11. Hum Mol Genet (1995) 1.49
Antibody-independent classical pathway-mediated opsonophagocytosis of type Ia, group B streptococcus. J Clin Invest (1982) 1.47
Treatment of pediatric low-grade gliomas with a nitrosourea-based multiagent chemotherapy regimen. J Neurooncol (1997) 1.47
The treatment of brain stem and thalamic gliomas with 78 Gy of hyperfractionated radiation therapy. Int J Radiat Oncol Biol Phys (1995) 1.45
Gamma knife radiosurgery in children. Pediatr Neurosurg (1996) 1.43
Phenotypic differences among patients with Bardet-Biedl syndrome linked to three different chromosome loci. Am J Med Genet (1995) 1.43
Congenital nasal masses: CT and MR imaging features in 16 cases. AJNR Am J Neuroradiol (1991) 1.42
A mouse model of chronic pulmonary infection with Pseudomonas aeruginosa and Pseudomonas cepacia. Pediatr Res (1987) 1.42
Quantitative determination of antibodies to type III group B streptococcal polysaccharide. J Infect Dis (1996) 1.41
A randomized clinical trial of daily nonstress testing versus biophysical profile in the management of preterm premature rupture of membranes. Am J Obstet Gynecol (1999) 1.39
Meningeal inflammation in neonatal gram-negative bacteremia. Pediatr Infect Dis J (1995) 1.38
Construction and partial characterization of two recombinant cDNA clones for procollagen from chicken cartilage. Nucleic Acids Res (1982) 1.35
Glucocorticoid induction of the glaucoma gene MYOC in human and monkey trabecular meshwork cells and tissues. Invest Ophthalmol Vis Sci (2001) 1.33
Group B streptococcal conjugate vaccines. Arch Dis Child (2003) 1.32
Psoas abscess in children. Pediatr Infect Dis J (1990) 1.32
Clinical and genetic analysis of a family affected with dominant optic atrophy (OPA1) Arch Ophthalmol (1997) 1.32
Regulation of transcription of genes required for fatty acid transport and unsaturated fatty acid biosynthesis in Escherichia coli by FadR. Mol Microbiol (1993) 1.32
Radiologic classification of brain stem tumors: correlation of magnetic resonance imaging appearance with clinical outcome. Pediatr Neurosurg (1996) 1.31
Expression pattern and in situ localization of the mouse homologue of the human MYOC (GLC1A) gene in adult brain. Brain Res Mol Brain Res (1999) 1.31
Survival and quality of life after interstitial implantation of removable high-activity iodine-125 sources for the treatment of patients with recurrent malignant gliomas. Int J Radiat Oncol Biol Phys (1989) 1.31
Functional differences of the PDS gene product are associated with phenotypic variation in patients with Pendred syndrome and non-syndromic hearing loss (DFNB4). Hum Mol Genet (2000) 1.30
Characterization of the MODY3 phenotype. Early-onset diabetes caused by an insulin secretion defect. J Clin Invest (1997) 1.30
Nonoperative treatment of brain abscesses in selected high-risk patients. J Neurosurg (1980) 1.30
Intracranial arachnoid cysts in children. A comparison of the effects of fenestration and shunting. J Neurosurg (1991) 1.28